FLUARIX

Category: Tag:

Description

FLUARIX® is a split virion (split virus) inactivated Influenza vaccine. The virus is concentrated, inactivated and “split” by disrupting its membranes from  Influenza viruses propagated in embryonated chicken eggs. FLUARIX is a vaccine indicated for active immunization for the prevention of disease caused by Influenza A subtype viruses and type B virus contained in the vaccine. FLUARIX is approved for use in persons 3 years of age and older.

FLUARIX has been standardized according to the WHO recommendations of 2015-16 influenza season and is formulated to contain
  • A/Christchurch/16/2010 NIB 74 XP (H1N1) (an A/California/7/ 2009-like virus)
  • A/Switzerland/9715293/ 2013 NIB-88 (H3N2)
  • B/Phuket/ 3073/2013

Immunization Guideline:

Children 3 through 8 years of age who are not previously vaccinated with influenza vaccine should receive two doses (0.5-mL each) at least 4 weeks apart. Children vaccinated with influenza vaccine in a previous season should receive one or two doses of 0.5-mL each (2 doses at an interval of 4 weeks).

9 years of age and older can receive one 0.5-mL dose.

Additional information

manufacturer

GlaxoSmithKline

country-of-manufacture

Germany

vaccine-type

Influenza

pharmaceutical-form

Liquid

package-size

1 Dose

route-of-administration

Intramuscular

preservative

None

Contraindications

Do not administer FLUARIX to anyone with a history of severe allergic reactions (e.g.anaphylaxis) to any component of the vaccine,including egg protein, or following a previous administration of any influenza vaccine.

Get FREE personalised Vaccination Chart and SMS reminders

Start Now